210 related articles for article (PubMed ID: 30418577)
21. Fluoroquinolone and quinazolinedione activities against wild-type and gyrase mutant strains of Mycobacterium smegmatis.
Malik M; Marks KR; Mustaev A; Zhao X; Chavda K; Kerns RJ; Drlica K
Antimicrob Agents Chemother; 2011 May; 55(5):2335-43. PubMed ID: 21383100
[TBL] [Abstract][Full Text] [Related]
22. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR.
van Doorn HR; An DD; de Jong MD; Lan NT; Hoa DV; Quy HT; Chau NV; Duy PM; Tho DQ; Chinh NT; Farrar JJ; Caws M
Int J Tuberc Lung Dis; 2008 Jul; 12(7):736-42. PubMed ID: 18544197
[TBL] [Abstract][Full Text] [Related]
23. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
Caspar Y; Siebert C; Sutera V; Villers C; Aubry A; Mayer C; Maurin M; Renesto P
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167561
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange.
Pavelka MS; Jacobs WR
J Bacteriol; 1999 Aug; 181(16):4780-9. PubMed ID: 10438745
[TBL] [Abstract][Full Text] [Related]
25. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
[TBL] [Abstract][Full Text] [Related]
26. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
Takiff HE; Salazar L; Guerrero C; Philipp W; Huang WM; Kreiswirth B; Cole ST; Jacobs WR; Telenti A
Antimicrob Agents Chemother; 1994 Apr; 38(4):773-80. PubMed ID: 8031045
[TBL] [Abstract][Full Text] [Related]
27. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
Maruri F; Sterling TR; Kaiga AW; Blackman A; van der Heijden YF; Mayer C; Cambau E; Aubry A
J Antimicrob Chemother; 2012 Apr; 67(4):819-31. PubMed ID: 22279180
[TBL] [Abstract][Full Text] [Related]
28. Influence of lineage-specific amino acid dimorphisms in GyrA on Mycobacterium tuberculosis resistance to fluoroquinolones.
Kim H; Nakajima C; Kim YU; Yokoyama K; Suzuki Y
Jpn J Infect Dis; 2012; 65(1):72-4. PubMed ID: 22274162
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.
Giannoni F; Iona E; Sementilli F; Brunori L; Pardini M; Migliori GB; Orefici G; Fattorini L
Antimicrob Agents Chemother; 2005 Jul; 49(7):2928-33. PubMed ID: 15980370
[TBL] [Abstract][Full Text] [Related]
30. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure.
Sutera V; Hoarau G; Renesto P; Caspar Y; Maurin M
Int J Antimicrob Agents; 2017 Sep; 50(3):377-383. PubMed ID: 28689870
[TBL] [Abstract][Full Text] [Related]
32. Multiplex allele-specific PCR combined with PCR-RFLP analysis for rapid detection of gyrA gene fluoroquinolone resistance mutations in Mycobacterium tuberculosis.
Zhao LL; Xia Q; Lin N; Liu ZG; Zhao XQ; Wan KL
J Microbiol Methods; 2012 Jan; 88(1):175-8. PubMed ID: 22115861
[TBL] [Abstract][Full Text] [Related]
33. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
Huang TS; Kunin CM; Shin-Jung Lee S; Chen YS; Tu HZ; Liu YC
J Antimicrob Chemother; 2005 Dec; 56(6):1058-62. PubMed ID: 16204341
[TBL] [Abstract][Full Text] [Related]
34. Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria.
Wang S; Zhang J; Hameed HMA; Ding J; Guan P; Fang X; Peng J; Su B; Ma S; Tan Y; M Cook G; Zhang G; Lin Y; Zhong N; Hu J; Liu J; Zhang T
Microbiol Spectr; 2023 Dec; 11(6):e0280923. PubMed ID: 37831477
[TBL] [Abstract][Full Text] [Related]
35. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
Altaf M; Miller CH; Bellows DS; O'Toole R
Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
Chauffour A; Morel F; Reibel F; Petrella S; Mayer C; Cambau E; Aubry A
Clin Microbiol Infect; 2021 Nov; 27(11):1601-1612. PubMed ID: 34265461
[TBL] [Abstract][Full Text] [Related]
38. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.
Duong DA; Nguyen TH; Nguyen TN; Dai VH; Dang TM; Vo SK; Do DA; Nguyen VV; Nguyen HD; Dinh NS; Farrar J; Caws M
Antimicrob Agents Chemother; 2009 Nov; 53(11):4835-9. PubMed ID: 19721073
[TBL] [Abstract][Full Text] [Related]
39. Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay.
Chakravorty S; Aladegbami B; Thoms K; Lee JS; Lee EG; Rajan V; Cho EJ; Kim H; Kwak H; Kurepina N; Cho SN; Kreiswirth B; Via LE; Barry CE; Alland D
J Clin Microbiol; 2011 Mar; 49(3):932-40. PubMed ID: 21191047
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
